|
2025
|
P/S
|
Clinical medical diagnostic services; Medical information; Provision of online medical informatio... |
|
2024
|
Invention
|
Pharmaceutical composition and use thereof. The present invention belongs to the technical field ... |
|
|
Invention
|
Nlrp3 inflammasome inhibitor and use thereof. 33 (I). |
|
|
Invention
|
Pharmaceutical composition and use thereof. A pharmaceutical composition and a use thereof, speci... |
|
2023
|
Invention
|
Nlrp3 inflammasome inhibitor and use thereof. 33 (A') |
|
|
Invention
|
Crystal form of imidazopyrazine derivative, preparation method therefor and use thereof. The pres... |
|
|
Invention
|
Crystalline form of quinoline derivative inhibitor, preparation method therefor and use thereof. ... |
|
|
Invention
|
Nlrp3 inflammasome inhibitor and uses thereof.
The present application belongs to the technical ... |
|
|
Invention
|
Nlrp3 inflammasome inhibitor and uses thereof. The present application belongs to the technical f... |
|
2022
|
Invention
|
Cdk9 inhibitor and use thereof.
The present invention falls within the technical field of medici... |
|
|
Invention
|
Cdk9 inhibitor and use thereof. The present invention relates to the field of medicines, specific... |
|
|
Invention
|
Cdk9 inhibitor and use thereof. 1212366, A, L, n, and m are as defined in the description. The co... |
|
|
Invention
|
New use of kinase inhibitor. The present invention belongs to the technical field of medicines, a... |
|
|
Invention
|
Novel application of kinase inhibitor.
The present invention belongs to the technical field of m... |
|
|
Invention
|
Novel use of kinase inhibitor. A novel application of a kinase inhibitor. An application of a com... |
|
|
Invention
|
Novel application of kinase inhibitor. A novel application of a kinase inhibitor. An application ... |
|
|
P/S
|
Medicines for human purposes; pharmaceutical preparations; chemico-pharmaceutical preparations; v... |
|
|
P/S
|
Telemedicine services; medical information services provided via the Internet; physical therapy s... |
|
|
P/S
|
Medicines for human purposes; pharmaceutical preparations;
chemico-pharmaceutical preparations; ... |
|
|
P/S
|
Vaccines; Chemical preparations for pharmaceutical or medical purposes, namely, for treatment of ... |
|
|
P/S
|
Presentation of goods on communication media in the nature of providing television home shopping ... |
|
|
P/S
|
Medicines for human purposes; pharmaceutical preparations; drugs for medical purposes; chemico-ph... |
|
|
P/S
|
Medicines for human purposes; pharmaceutical preparations;
drugs for medical purposes; chemico-p... |
|
|
P/S
|
Medicines for human purposes for treatment of cancer, cardiovascular diseases and disorders, meta... |
|
|
Invention
|
Nlrp3 inflammasome inhibitor and application thereof.
The present invention belongs to the techn... |
|
|
Invention
|
Nlrp3 inflammasome inhibitor and application thereof. The present invention relates to the techni... |
|
|
Invention
|
Pharmaceutical composition and use of multi-kinase inhibitor.
A pharmaceutical composition and u... |
|
|
Invention
|
Pharmaceutical composition and use of multi-kinase inhibitor. 1111, and Ar in general formula (I)... |
|
|
Invention
|
Method for preparing phosphodiesterase inhibitor.
The present invention belongs to the technical... |
|
|
Invention
|
Method for preparing phosphodiesterase inhibitor. The present invention belongs to the technical ... |
|
|
Invention
|
Combined use of multikinase inhibitor.
The present invention relates to a pharmaceutical composi... |
|
|
Invention
|
Combined use of multikinase inhibitor. The present invention relates to a pharmaceutical composit... |
|
|
Invention
|
Substituted imidazo[1,5-a]pyrazines as bruton's tyrosine kinase inhibitors. The present invention... |
|
2021
|
Invention
|
Crystal form of fibroblast growth factor receptor inhibitor and preparation method therefor.
The... |
|
|
Invention
|
Crystal form of fibroblast growth factor receptor inhibitor and preparation method therefor. The ... |
|
|
Invention
|
Method for synthesizing anti-tumor compound and intermediates thereof.
The present invention bel... |
|
|
Invention
|
Method for synthesizing anti-tumor compound and intermediates thereof. The present invention belo... |
|
|
Invention
|
Novel use of multikinase inhibitor.
The present invention belongs to the technical field of medi... |
|
|
Invention
|
Multi-kinase inhibitor for treatment of biliary tract cancer. Provided in the present invention a... |
|
|
Invention
|
Pde9 inhibitor and use thereof. 2, ring A, L and m are as defined in the description. The compoun... |
|
2020
|
Invention
|
Method for treating a cancer mediated by abnormality of multi-kinases. e][1,4]diazepin-8-yl)morph... |
|
|
Invention
|
Heterocyclic derivative and use thereof.
Disclosed are a TAM family kinase/and Ron kinase inhibi... |
|
|
Invention
|
Crystal form of phosphodiesterase inhibitor, preparation method therefor and use thereof. The pre... |
|
|
Invention
|
Crystal form of phosphodiesterase inhibitor, preparation method therefor and use thereof. T... |
|
|
Invention
|
Uses of phosphodiesterase inhibitors.
Disclosed are uses of a compound represented by general fo... |
|
|
Invention
|
Uses of phosphodiesterase inhibitors. Disclosed are uses of a compound represented by gener... |
|
|
Invention
|
Pde9 inhibitor and use thereof.
The present invention relates to the technical field of pharmace... |
|
|
Invention
|
Haloallylamine compounds and application thereof.
The present invention relates to the technical... |
|
|
Invention
|
Halo-allylamine compounds and use thereof. The present invention relates to the technical field o... |
|
2019
|
Invention
|
Quinoline derivative inhibitor: tam, ntrk, and csf1r kinases. Provided by the present invention i... |
|
|
Invention
|
Aminonorbornane derivative and manufacture method therefor and use thereof. The present invention... |
|
|
Invention
|
Multi-kinase inhibitor compound, and crystal form and use thereof. 2, X, Y, P, W, and Ar are as d... |
|
2018
|
Invention
|
Halo-allylamine ssao/vap-1 inhibitor and use thereof. 7 are defined as in the specification; the ... |
|
2017
|
Invention
|
Inhibitors of fibroblast growth factor receptor and use thereof. 4, ring A, Ar, ring B and warhea... |
